Summit Investment Advisors »

Crinetics Pharmaceuticals In shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $241k 6.8k 35.58
2023-09-30 $193k 6.5k 29.74
2023-06-30 $72k 4.0k 18.02
2023-03-31 $64k 4.0k 16.06
2022-12-31 $79k 4.0k 19.90
2022-09-30 $78k 4.0k 19.56
2022-06-30 $74k 4.0k 18.56
2022-03-31 $78k 3.6k 21.90
2021-12-31 $101k 3.6k 28.35
2021-09-30 $60k 2.9k 20.98
2021-06-30 $54k 2.9k 18.88
2021-03-31 $37k 2.4k 15.48
2020-12-31 $34k 2.4k 14.23
2020-09-30 $37k 2.4k 15.48
2020-06-30 $42k 2.4k 17.57
2020-03-31 $14k 952 14.71
2019-12-31 $24k 952 25.21
2019-09-30 $14k 952 14.71
2019-06-30 $24k 952 25.21
2019-03-31 $13k 574 22.65
2018-12-31 $17k 574 29.62
2018-09-30 $16k 574 27.87